Modulation of animal and human hematopoiesis by β-glucans: A review

Molecules

Volumn 16, Issue 9, 2011, Pages 7969-7979

  Hofer, Michal ^a   Pospíšil, Milan ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

glucan; Hematopoiesis; Myelosuppression

Indexed keywords

ANTIANEMIC AGENT; ANTINEOPLASTIC AGENT; BETA GLUCAN;

ANEMIA; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG DOSAGE FORM; DRUG EFFECT; HEMATOPOIESIS; HUMAN; RADIATION EXPOSURE; RADIOTHERAPY; REVIEW;

ANEMIA; ANIMALS; ANTINEOPLASTIC AGENTS; BETA-GLUCANS; DOSAGE FORMS; HEMATINICS; HEMATOPOIESIS; HUMANS; RADIOTHERAPY;

EID: 80053224997     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16097969     Document Type: Review

References (72)

1. Pilemer, L.; Ecker, E.E. Anticomplementary factor in fresh yeast. J. Biol. Chem. 1941, 137, 139-142.
2. Di Carlo, F.J.; Fiore, J.V. On the composition of zymosan. Science 1958, 127, 756-757.
3. Riggi, S.J.; DiLuzio, N.R. Identification of a reticuloendothelial stimulatory agent in zymosan. Am. J. Physiol. 1961, 200, 297-300.
4. Dunlap, J.; Minami, E.; Bhagwat, A.A.; Keister, D.L.; Stacey, G. Nodule development induced by mutants of Bradyrhizobium japonicum defective in cyclic B-glucan synthesis. Mol. Plant Microbe Interact. 1996, 9, 546-555. (Pubitemid 27027363)
5. Magnani, M.; Castro-Gomez, R.H.; Aoki, M.N.; Gregorio, E.P.; Libos, F.; Watanabe, M.A.E. Effects of carboxymethyl-glucan from Saccharomyces cerevisiae on the peripheral blood cells of patients with advanced prostate cancer. Exp. Ther. Med. 2010, 5, 859-862.
6. Ohno, N.; Miura, N.N.; Nakajima, M.; Yadomae, T. Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa. Biol. Pharm. Bull. 2000, 23, 866-872. (Pubitemid 30484387)
7. Chang, R. Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. J. Altern. Complement. Med. 2002, 8, 559-565. (Pubitemid 35291590)
8. Marklinder, I.; Johansson, L.; Haglund, A.; NagelHeld, B.; Seibel, W. Effects of flour from different barley varieties on barley sour dough bread. Food Qual. Preference 1996, 7, 275-284. (Pubitemid 27094124)
9. Lin, H.; De Stanchina, E.; Zhou, X.K.; She, Y.; Hoang, D.; Cheung, S.W.Y.; Cassileth, B.; Cunningham-Rundles, S. Maitake beta-glucan enhances umbilical cord blood stem cell transplantation in the DOD/SCID mouse. Exp. Biol. Med. 2009, 234, 342-353.
10. DiLuzio, N.R. Immunopharmacology of glucan: A broad spectrum enhancer of host defense mechanisms. Trends Pharmacol. Sci. 1983, 4, 344-347.
11. DiLuzio, N.R. Update on the immunomodulating activities of glucan. Springer Semin. Immunopathol. 1985, 8, 387-400.
12. Kokoshis, P.L.; Williams, D.L.; Cook, J.A.; DiLuzio, N.R. Increased resistance to Staphylococcus-aureus infection and enhancement in serum lysozyme activity by glucan. Science 1987, 199, 1340-1342.
13. DiLuzio, N.R.; Williams, D.L. Protective effects of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infect. Immun. 1978, 20, 804-810. (Pubitemid 8352021)
14. Williams, D.L.; DiLuzio, N.R. Glucan-induced modification of murine viral-hepatitis. Science 1980, 208, 67-69.
15. Williams, D.L.; Cook, J.A.; Hoffmann, E.O.; DiLuzio, N.R. Protective effects of glucan in experimentally induced candidiasis. J. Reticuloendothel. Soc. 1978, 23, 479-490. (Pubitemid 8394904)
16. Browder, I.W.; Williams, D.L.; Kitahama, A.; DiLuzio, N.R. Modification of postoperative C-albicans sepsis by glucan immunostimulation. Int. J. Immunopharmacol. 1984, 6, 19-26. (Pubitemid 14127376)
17. Williams, D.L.; Mueller, A.; Browder, W. Glucan-based macrophage stimulators: A review of their anti-infective potential. Clin. Immunother. 1996, 9, 392-399.
18. - cells in lymphohematopoiesis. Leuk. Lymphoma 1998, 31, 285-293. (Pubitemid 29033949)
19. Grande, T.; Varas, F.; Bueren, J.A. Residual damage of lymphohematopoietic repopulating cells after irradiation of mice at different stages of development. Exp. Hematol. 2000, 28, 87-95. (Pubitemid 30047194)
20. Burgaleta, C.; Golde, D.W. Effect of glucan on granulopoiesis and macrophage genesis in mice. Cancer Res. 1977, 37, 1739-1742. (Pubitemid 8098520)
21. Niskanen, E.O.; Burgaleta, C.; Cline, M.J.; Golde, D.W. Effect of glucan, a macrophage activator, on murine hemopoietic cell proliferation in diffusion chambers in mice. Cancer Res. 1978, 38, 1406-1409. (Pubitemid 8323346)
22. Patchen, M.L.; Lotzová, E. Modulation of murine hemopoiesis by glucan. Exp. Hematol. 1980, 8, 409-422. (Pubitemid 10153365)
23. Patchen, M.L.; MacVittie, T.J. Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan. Immunopharmacology 1983, 5, 303-313. (Pubitemid 14171821)
24. Patchen, M.L.; MacVittie, T.J. Temporal response of murine pluripotent stem cells and myeloid and erythroid progenitor cells to low-dose glucan treatment. Acta Haematol. 1983, 70, 281-288. (Pubitemid 13011214)
25. Patchen, M.L.; MacVittie, T.J. Hemopoietic effects of intravenous soluble glucan administration. J. Immunopharmacol. 1986, 8, 407-425. (Pubitemid 16017203)
26. Hashimoto, K.; Suzuki, I.; Ohsawa, M.; Oikawa, S.; Yadomae, T. Enhancement of hematopoietic response of mice by intraperitoneal administration of a β-glucan, SSG, obtained from Sclerotinia sclerotiorum. J. Pharmacobio-Dyn. 1990, 13, 512-517. (Pubitemid 20317189)
27. PospíŠil, M.; Jarý, J.; Netíková, J.; Marek, M. Glucan-induced enhancement of hemopoietic recovery in gamma-irradiated mice. Experientia 1982, 38, 1232-1234. (Pubitemid 13200514)
28. PospíŠil, M.; Šandula, J.; Pipalová, I.; Hofer, M.; Viklická, Š. Hemopoiesis stimulating and radioprotective effects of carboxymethylglucan. Physiol. Res. 1991, 40, 377-380.
29. Hofer, M.; PospíŠil, M.; Viklická, Š.; Pipalová, I.; Holá, J.; Netíková, J.; Šandula, J. Effects of postirradiation carboxymethylglucan administration in mice. Int. J. Immunopharmacol. 1995, 17, 167-174.
30. Hofer, M.; PospíŠil, M.; Pipalová, I.; Holá, J.; Šandula, J. Haemopoiesis-enhancing effects of repeatedly administered carboxymethylglucan in mice exposed to fractionated irradiation. Folia Biol. (Praha) 1995, 41, 249-256.
31. Hofer, M.; PospíŠil, M. Glucan as stimulator of hematopoiesis in normal and gamma-irradiated mice. A survey of the authors' results. Int. J. Immunopharmacol. 1997, 19, 607-609. (Pubitemid 28261022)
32. Patchen, M.L.; MacVittie, T.J. Macrophages and Natural Killer Cells; Norman, J.J., Sorkin, E., Eds.; Plenum Publishing Corporation: New York, NY, USA, 1982; pp. 267-272.
33. Patchen, M.L.; MacVittie, T.J. Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int. J. Immunopharmacol. 1985, 7, 923-932. (Pubitemid 16213261)
34. Patchen, M.L.; MacVittie, T.J.; Wathen, L.M. Effects of pre-and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage and erythroid progenitor cells, and hemopoietic stromal cells. Experientia 1984, 40, 1240-1244. (Pubitemid 15077839)
35. Patchen, M.L.; MacVittie, T.J.; Brook, I. Glucan-induced hemopoietic and immune stimulation: Therapeutic effects in sublethally and lethally irradiated mice. Meth. Find. Exp. Clin. Pharmacol. 1986, 8, 151-155. (Pubitemid 16131942)
36. Patchen, M.L.; D'Alesandro, M.M.; Brook, I.; Blakely, W.F.; MacVittie, T.J. Glucan: Mechanisms involved in its "radioprotective" effect. J. Leukoc. Biol. 1987, 42, 95-105. (Pubitemid 17099551)
37. Patchen, M.L.; DiLuzio, N.R.; Jacques, P.; MacVittie, T.J. Soluble polyglycans enhance recovery from cobalt-60-induced hemopoietic injury. J. Biol. Response Mod. 1984, 3, 627-633. (Pubitemid 15175575)
38. Patchen, M.L.; Brook, I.; Elliott, T.B.; Jackson, W.E. Adverse effects of pefloxacin in irradiated C3H/HeN mice: Correction with glucan therapy. Antimicrob. Agents Chemother. 1993, 37, 1882-1889. (Pubitemid 23265547)
39. PospíŠil, M.; Netíková, J.; Pipalová, I.; Jarý, J. Combined radioprotection by preirradiation peroral cystamine and postirradiation glucan administration. Folia Biol. (Praha) 1991, 37, 117-124.
40. Patchen, M.L.; D'Alesandro, M.M.; Chirigos, M.A.; Weiss, J.F. Radioprotection by biological response modifiers alone and in combination with WR-2721. Pharmacol. Ther. 1988, 39, 247-254.
41. Patchen, M.L.; MacVittie, T.J.; Weiss, J.F. Combined modality radioprotection: The use of glucan and selenium with WR-2721. Int. J. Radiat. Oncol. Biol. Phys. 1990, 18, 1069-1075. (Pubitemid 20182339)
42. Patchen, M.L.; MacVittie, T.J.; Solberg, B.D.; Souza, L.M. Survival enhancement and hemopoietic regeneration following radiation exposure: Therapeutic approach using glucan and granulocyte colony-stimulating factor. Exp. Hematol. 1990, 18, 1042-1048.
43. PospíŠil, M.; Hofer, M.; Pipalová, I.; Viklická, Š.; Netíková, J.; Šandula, J. Enhancement of hematopoietic recovery in gamma-irradiated mice by the joint use of diclofenac, an inhibitor of prostaglandin production, and glucan, a macrophage activator. Exp. Hematol. 1992, 20, 891-895.
44. Hofer, M.; PospíŠil, M.; Viklická, Š.; Vacek, A.; Pipalová, I.; BartoníČková, A. Hematopoietic recovery in repeatedly irradiated mice can be enhanced by a repeatedly administered combination of diclofenac and glucan. J. Leukoc. Biol. 1993, 53, 185-189. (Pubitemid 23100162)
45. LíŠková, A.; Wagnerová, J.; Červenáková, L.; KriŠtofová, A.; Ferencík, M. The effect of soluble glucan derivates on spleen colony-forming units in sublethally irradiated mice. Folia Microbiol. 1990, 35, 353-362. (Pubitemid 20338439)
46. Cramer, D.E.; Allendorf, D.J.; Baran, J.T.; Hansen, R.; Marroquin, J.; Li, B.; Ratajczak, J.; Ratajczak, M.Z.; Yan, J. P-Glucan enhances complement-mediated hematopoietic recovery after bone marrow injury. Blood 2006, 107, 835-840. (Pubitemid 43076413)
47. Wagnerová, J.; LíŠková, A.; Navarová, J.; KriŠtofová, A.; Trnovec, T.; Ferencík, M. The effects of two glucan carboxymethylderivatives with various substitution degress on cyclophosphamide immunosuppression in mice. Immunopharmacol. Immunotoxicol. 1993, 15, 227-242. (Pubitemid 23188515)
48. Patchen, M.L.; Vaudrain, T.; Correira, H.; Martin, T.; Reese, D. In vitro and in vivo hematopoietic activities of Betafectin® PGG-glucan. Exp. Hematol. 1998, 13, 1247-1254. (Pubitemid 28541768)
49. Lin, H.; She, Y.-H; Cassileth, B.R.; Sirotnak, F.; Cunningham-Rundles, S. Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int. Immunopharmacol. 2004, 4, 91-99. (Pubitemid 38223818)
50. Ito, K.; Masuda, Y.; Yamasaki, Y.; Yokota, Y.; Nanba, H. Maitake beta-glucan enhances granulopoiesis and mobilization of granulocytes by increasing G-CSF production and modulating CXCR4/SDF-1 expression. Int. Immunopharmacol. 2009, 9, 1189-1196.
51. Harnack, U.; Eckert, K.; Fichtner, I.; Pecher, G. Comparison of the effect of orally administered soluble beta-(1,3),(1,6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis. In Vivo 2010, 24, 59-63.
52. Lin, H.; Cheung, S.W.Y.; Nesin, M.; Cassileth, B.R.; Cunningham-Rundles, S. Enhancement of umbilical cord blood cell hematopoiesis by maitake beta-glucan is mediated by granulocyte colony-stimulating factor production. Clin. Vaccine Immunol. 2007, 14, 21-27.
53. Patchen, M.L.; Liang, J.; Vaudrain, T.; Martin, T.; Melican, D.; Zhong, S.; Stewart, M.; Quesenberry, P.J. Mobilization of peripheral blood progenitor cells by betafectin® PGG-glucan alone and in combination with granulocyte colony-stimulating factor. Stem Cells 1998, 16, 208-217. (Pubitemid 28235165)
54. Torello, CO.; de Souza Queiroz, J.; OLiveira, S.C.; Queiroz, M.L.S. Immunohematopoietic modulation by oral P-1,3-glucan in mice infected with Listeria monocytogenes. Int. Immunopharmacol. 2010, 10, 1573-1579.
55. Sherwood, E.R.; Williams, D.L.; McNamee, R.B.; Jones, E.L.; Browder, I.W.; Di Luzio, N.R. Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. Int. J. Immunopharmacol. 1987, 9, 261-267. (Pubitemid 17080236)
56. Abel, G.; Czop, J.K. Stimulation of human monocyte P-glucan receptors by glucan particles induces production of TNF-a and IL-1p. Int. J. Immunopharmacol. 1992, 14, 1363-1373.
57. Dorie, M.J.; Allison, A.C.; Zaghloul, M.S.; Kallman, R.F. Interleukin 1 protects against the lethal effects of irradiation of mice but has no effect on tumors in the same animals. Proc. Soc. Exp. Biol. Med. 1989, 191, 23-29. (Pubitemid 19126438)
58. Turnbull, J.L.; Patchen, M.L.; Scadden, D.T. The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines. Acta Haematol. 1999, 102, 66-71. (Pubitemid 29469145)
59. Deimann, W.; Fahimi, H.D. Hepatic granulomas induced by glucan. An ultrastructural and peroxidase-cytochemical study. Lab. Invest. 1980, 43, 172-181. (Pubitemid 10043147)
60. Kimura, A.; Sherwood, R.L.; Goldstein, E. Glucan alteration of pulmonary antibacterial defense. J. Reticuloendothel. Soc. 1983, 34, 1-11. (Pubitemid 13012978)
61. PospíŠil, M.; TkadleČek, L.; Netíková, J.; Pipalová, I.; Viklická, Š.; Kozubík, A.; Vácha, J.; Jarý, J. Interstrain differences in the responsivenss of mice to glucan with respect to hematological effects and manifestations of late damage. Exp. Pathol. 1988, 33, 27-36.
62. Bowers, G.J.; Patchen, M.L.; MacVittie, T.J.; Hirsch, E.F.; Fink, M.P. A comparative evaluation of particulate and soluble glucan in an endotoxin model. Int. J. Immunopharmacol. 1986, 8, 313-321. (Pubitemid 16097757)
63. Di Luzio, N.R.; Williams, D.L.; McNamee, R.B.; Edwards, B.F.; Kitahama, A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int. J. Cancer 1979, 24, 773-779. (Pubitemid 10202851)
64. Baker, W.H.; Nold, J.B.; Patchen, M.L.; Jackson, W.E. Histopathologic effects of soluble glucan and WR-2721, independently and combined in C3H/HeN mice. Proc. Soc. Exp. Biol. Med. 1992, 201, 180-191.
65. Vácha, J.; Znojil, V.; PospíŠil, M.; Holá, J.; Pipalová, I. Microcytic anemia and changes in ferrokinetics as late after-effects of glucan administration in murine hepatitis virus-infected C57BL/10ScSnPh mice. Int. J. Immunopharmacol. 1994, 16, 51-60. (Pubitemid 24049335)
66. PospíŠil, M.; Vacek, A.; Hofer, M.; Viklická, Š.; Pipalová, I.; Šandula, J. Hyporesponsiveness of murine myeloid progenitor cells to glucan following its repeated administration. Folia Biol. (Praha) 1993, 178-187. (Pubitemid 24080971)
67. Williams, D.L.; Sherwood, E.R.; Browder, I.W.; McNamee, R.B.; Jones, E.L.; DiLuzio, N.R. Pre-clinical safety evaluation of soluble glucan. Int. J. Immunopharmacol. 1988, 10, 405-414.
68. Browder, W.; Williams, D.; Pretus, H.; Oliveiro, G.; Enrichens, F.; Mao, P.; Franchello, A. Beneficial effect of enhanced macrophage function in the trauma patient. Ann. Surg. 1990, 211, 605-613. (Pubitemid 20155699)
69. Spruijt, N.E.; Visser, T.; Leenen, L.P.H. A systematic review of randomized controlled trials exploring the effect of immunomodulative interventions on infection, organ failure, and mortality in trauma patients. Crit. Care 2010, 14, R150.
70. Babineau, T.J.; Marcello, P.; Swails, W.; Kenler, A.; Bistrian, B.; Forse, R.A. Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann. Surg. 1994, 220, 601-609.
71. Weitberg, A.B. A phase I/II trial of beta-(1,3)/(1,6) D-glucan in the treatment of patients with advanced malignancies receiving chemotherapy. J. Exp. Clin. Cancer Res. 2008, 27, 40.
72. Hong, F.; Yan, J.; Baran, J.T.; Allendorf, D.J.; Hansen, R.D.; Ostroff, R.; Xing, P.X.; Cheung, N.-K.V.; Ross, G.D. Mechanisms by which orally administered β-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 2004, 173, 797-806 (Pubitemid 38924254)